Gardere partner Randy D. Gordon, chair of the firm’s antitrust and trade regulation practice group, published an article with Law360 regarding the recent recasting of the proposed Walgreens-Rite Aid merger as a partial acquisition.
“Instead of a complete walkaway, Walgreens has now proposed to buy about half of Rite Aid’s stores. If this arrangement is sustained, which Walgreens’ CEO Stefano Pessina believes will be the case, Walgreens will hold a strong position against its principal rival, CVS,” Gordon said.
Subscribers can access the full article here.
Related Insights
May 1, 2026
Manufacturing Industry Advisor
A New DOL Joint Employment Rule? What Franchisors Need to Know
On April 22, 2026, the U.S. Department of Labor's Wage and Hour Division published a proposed rule to establish a single, nationwide…
May 27, 2026
Events
ABA’s Qui Tam & Civil False Claims and Healthcare Fraud Institute 2026
Foley partner Lisa Noller, Chair of the Firm’s Litigation Department, will be speaking at the American Bar Association’s Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C. from May 27-28.
April 30, 2026
Foley Viewpoints
Sizing Up The 3-Way Battle For 'Iceman' IP Rights
Trademark rights in the U.S. arise from use in commerce, not from registration alone. The Lanham Act's first-to-use framework means that a party who can demonstrate earlier, continuous commercial use of a mark holds superior rights over a later filer. This principle is the backbone of Gervin's case against Williams.